Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine
- PMID: 20198473
- PMCID: PMC2844965
- DOI: 10.1007/s00259-010-1394-4
Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine
Erratum in
- Eur J Nucl Med Mol Imaging.2010 Jun;37(6):1235
Abstract
We describe here a protocol for labelling autologous white blood cells with (99m)Tc-HMPAO based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.
References
-
- Guidelines on current good radiopharmacy practice (cGRPP) in the preparation of radiopharmaceuticals. EANM Radiopharmacy committee. Eur J Nucl Med Mol Imaging 2009 (in press), https://www.eanm.org/scientific_info/guidelines/gl_radioph_cgrpp.pdf - PMC - PubMed
-
- Ak I, Vardereli E, Durak B, Gülbaş Z, Basaran N, Stokkel MPM, et al. Labeling of mixed leukocytes with 99mTc-HMPAO causes severe chromosomal aberrations in lymphocytes. J Nucl Med. 2002;43:203–206. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources